A strategy for inducing immune tolerance to valve endothelial cells through gene transfer

Journal of Heart Valve Disease

Volumn 9, Issue 3, 2000, Pages 439-444

  Li, Ying ^a   McCormack, Ann M ^a   Brand, Nigel J ^a   Yacoub, Magdi H ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; COMPLEMENTARY DNA; DNA; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; NEOMYCIN; PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GENE; GENE TRANSFER; HEART VALVE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOLOGICAL TOLERANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; ENDOTHELIUM; FAS LIGAND PROTEIN; GRAFT REJECTION; HEART VALVES; HUMANS; MEMBRANE GLYCOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSFECTION; TRANSPLANTATION TOLERANCE;

EID: 0034080225     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Smith JD, Hornick PI, Rasmi N, Rose ML, Yacoub MH. Effect of HLA mismatching and antibody status on 'homovital' aortic valve homograft performance. Ann Thorac Surg 1998;66(suppl.6): S212-S215
2. Yacoub MH, Suitters A, Khagani A, Rose ML. Localisation of major histocompatibility complex antigens in aortic homografts. In: Bodnar E, Yacoub MH (ed). Biologic and bioprosthetic valves. Proceedings of the Third International Symposium. Yorke Medical Books, New York, 1986:63-72
3. Johnson DL, Rose ML, Yacoub MH. Immunogenicity of human heart valve endothelial cells and fibroblasts. Transplant Proc 1997;29:984-985
4. Yacoub MH, Rasmi NRH, Saundt TM, et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:186-194
5. Grafe M, Graf K, Auch-Schwelk W, Terbeek D, Hertel H, Fleck E. Cultivation and characterisation of micro and macrovascular endothelial cells from human heart. Eur Heart J 1993;Suppl.I:74-81
6. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, New York, 1989
7. Oei F, Welters M, Knoop C, et al. Donor-specific cellular and humoral response induced by implantation of cryopreserved human heart valves. Abstracts, World Symposium on Heart Valve Disease, 1999, London, Abstract #41
8. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-632
9. Lau HT, Yu M, Fontana A, Stoeckert CJ, Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996;273:109-112
10. Swenson KM, Ke B, Wang T, et al. Fas ligand gene transfer to renal allografts in rats: Effects on allograft survival. Transplantation 1998;65:155-160
11. Yagita H, Seino K, Kayagaki N, Okumura K. CD95 ligand in graft rejection. Nature 1996;379:682-683
12. Takeuchi T, Ueki T, Nishimatsu H, et al. Accelerated rejection of Fas ligand-expressing heart grafts. J Immunol 1999;2:518-522
13. Li XK, Okuyama T, Tamura A, et al. Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid. Transplantation 1998;66: 1416-1423
14. Sata M, Walsh K. TNF-[f symbol]a[r] regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nature Med 1998;4:415-420
15. Walsh K, Sata M. Is extravasation a Fas-regulated process? Mol Med Today 1999;2:61-67
16. Yacoub MH, Misfeld M, Kilner PJ. The aortic outflow and root - a tale of dynamism and crosstalk. Ann Thorac Surg (in press)
17. Yankah AC, Wottge HU, Muller-Ruchholtz W. Antigenicity and fate of cellular components of heart valve allografts. In: Yankah AC, Hetzer R, Miller DC, Ross DN, Sommerville J, Yacoub MH (ed). Cardiac Valve Allografts 1962-1987. Current concepts on the use of aortic and pulmonary allografts for heart valve substitutes. Steinkopf Verlag, Darmstadt, 1987:77-87
18. Vaux DL. Immunology. Ways around rejection (news; comment). Nature 1998;394:6689